• OPEN AN ACCOUNT
Indian Indices
Sensex
75,577.58 -555.23
( -0.73%)
Global Indices
Nasdaq
53,435.25 -271.85
(-0.51%)
Dow Jones
7,739.60 -29.11
(-0.37%)
Hang Seng
65,678.73 -721.11
(-1.09%)
Nikkei 225
10,811.26 -10.87
(-0.10%)
Forex
USD-INR
94.44 -0.05
(-0.05%)
EUR-INR
109.67 -0.05
(-0.04%)
GBP-INR
127.62 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Pritika Engineering Components Ltd
Industry :  Castings & Forgings
BSE Code
ISIN Demat
Book Value()
77883
INE0MJQ01020
19.8940851
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PRITIKA
24
167.02
EPS(TTM)
Face Value()
Div & Yield %
2.64
5
0
 

Bal Pharma consolidated net profit declines 33.89% in the March 2026 quarter
May 28,2026
Net profit of Bal Pharma declined 33.89% to Rs 3.59 crore in the quarter ended March 2026 as against Rs 5.43 crore during the previous quarter ended March 2025. Sales rose 2.69% to Rs 84.08 crore in the quarter ended March 2026 as against Rs 81.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 13.02% to Rs 6.28 crore in the year ended March 2026 as against Rs 7.22 crore during the previous year ended March 2025. Sales rose 2.83% to Rs 311.66 crore in the year ended March 2026 as against Rs 303.08 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales84.0881.88 3 311.66303.08 3
OPM %12.579.33 -10.249.75 -
PBDT6.284.77 32 17.0114.91 14
PBT3.222.59 24 5.935.14 15
NP3.595.43 -34 6.287.22 -13